Bright Minds Biosciences, Inc. (DRUG)
89.41
+0.74
(+0.83%)
USD |
NASDAQ |
Jan 13, 16:00
89.11
-0.30
(-0.34%)
After-Hours: 20:00
Bright Minds Biosciences EPS Diluted (Quarterly): -0.4138 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.966M |
| Total Expenses (Quarterly) | 2.966M |
| Enterprise Value | 810.66M |
| Earnings Yield | -1.38% |
| Normalized Earnings Yield | -1.382 |